Peter Kuehl

Roche (Switzerland)

Papers

2

Total Citations

17

H-Index

2

About

Peter Kuehl is a biomedical engineer whose research focuses on pediatric drug delivery and the biomechanics of swallowing. His work addresses a critical challenge in pharmaceutical development: designing solid oral dosage forms that are safe and acceptable for children. Kuehl’s major contributions include the development of a novel soft robotic pediatric in vitro swallowing device, which simulates the human swallowing process to test the swallowability of mini-tablets and multiparticulate formulations. This device, detailed in his most-cited paper (13 citations), provides a reproducible, ethical alternative to human trials for assessing oral drug product performance. His subsequent work (4 citations) explores how binary mixtures of mini-tablets and pellets can improve swallowability, directly informing the design of combination products for pediatric use. By bridging engineering and pharmaceutics, Kuehl is helping to move the field away from liquid formulations—which often suffer from poor palatability and dosing inaccuracies—toward more acceptable solid dosage forms. His research is vital for regulatory agencies and pharmaceutical companies aiming to improve medication adherence in children, and his innovative in vitro platform represents a significant step toward safer, more effective pediatric medicines.

Research Focus

Key Achievements

2
H-Index
2
Papers
17
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
A novel soft robotic pediatric in vitro swallowing device to gain insights into the swallowability of mini-tablets
13 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Roche (Switzerland)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 18 days ago